 |
|
Carbohydrate restriction may slow prostate tumor growth
May 27, 2009DURHAM, N.C. -- Restricting carbohydrates, regardless of weight loss, appears to slow the growth of prostate tumors, according to an animal study being published this week by researchers in the Duke Prostate Center.
"Previous work here and elsewhere has shown that a diet light in carbohydrates could slow tumor growth, but the animals in those studies also lost weight, and because we know that weight loss can restrict the amount of energy feeding tumors, we weren't able to tell just how big an impact the pure carbohydrate restriction was having, until now," said Stephen Freedland, M.D., a urologist in the Duke Prostate Center and lead investigator on this study.
The researchers believe that insulin and insulin-like growth factor contribute to the growth and proliferation of prostate cancer, and that a diet devoid of carbohydrates lowers serum insulin levels in the bodies of the mice, thereby slowing tumor growth, Freedland said.
The findings appear in the May 26, 2009 online edition of the journal Cancer Prevention Research. Funding was provided by the United States Department of Veterans Affairs, the Department of Defense Prostate Cancer Research Program; the American Urological Association/ Foundation Astellas Rising Star in Urology Award, and the Robert C. Atkins Foundation.
Animals in the study were fed one of three diets: a very high fat/ no carbohydrate diet; a low-fat/ high carbohydrate diet; and a high fat/ moderate-carbohydrate diet, which is most similar to the "Western" diet most Americans eat, Freedland said. They were then injected with prostate tumors at the same time.
"The mice that were fed a no-carbohydrate diet experienced a 40 to 50 percent prolonged survival over the other mice," Freedland said.
Mice on the no-carbohydrate diet consumed more calories in order to keep body weights consistent with mice on the other study arms.
"We found that carbohydrate restriction without energy restriction - or weight loss - does indeed result in tumor growth delay," he said.
The researchers plan to begin recruiting patients at two sites - Duke and the University of California - Los Angeles - for a clinical trial to determine if restricting carbohydrate intake in patients with prostate cancer can similarly slow tumor growth. The trial should begin within a few weeks.
"It's very exciting - this is a potential new mechanism to fight prostate cancer growth and help patients live longer with their disease," Freedland said.
Duke University Medical Center
The findings appear in the May 26, 2009 online edition of the journal Cancer Prevention Research. Funding was provided by the United States Department of Veterans Affairs, the Department of Defense Prostate Cancer Research Program; the American Urological Association/ Foundation Astellas Rising Star in Urology Award, and the Robert C. Atkins Foundation.
Animals in the study were fed one of three diets: a very high fat/ no carbohydrate diet; a low-fat/ high carbohydrate diet; and a high fat/ moderate-carbohydrate diet, which is most similar to the "Western" diet most Americans eat, Freedland said. They were then injected with prostate tumors at the same time.
"The mice that were fed a no-carbohydrate diet experienced a 40 to 50 percent prolonged survival over the other mice," Freedland said.
Mice on the no-carbohydrate diet consumed more calories in order to keep body weights consistent with mice on the other study arms.
"We found that carbohydrate restriction without energy restriction - or weight loss - does indeed result in tumor growth delay," he said.
The researchers plan to begin recruiting patients at two sites - Duke and the University of California - Los Angeles - for a clinical trial to determine if restricting carbohydrate intake in patients with prostate cancer can similarly slow tumor growth. The trial should begin within a few weeks.
"It's very exciting - this is a potential new mechanism to fight prostate cancer growth and help patients live longer with their disease," Freedland said.
Duke University Medical Center
Tumor Growth Current Events and Tumor Growth News RSS1930s drug slows tumor growth
Drugs sometimes have beneficial side effects. A glaucoma treatment causes luscious eyelashes. A blood pressure drug also aids those with a rare genetic disease.
Early-stage, HER2-positive breast cancer patients at increased risk of recurrence
Early-stage breast cancer patients with HER2 positive tumors one centimeter or smaller are at significant risk of recurrence of their disease, compared to those with early-stage disease who do not express the aggressive protein, according to a study led by researchers at The University of Texas M. D. Anderson Cancer Center.
Researchers use drug-radiation combo to eradicate lung cancer
Researchers at UT Southwestern Medical Center have eliminated non-small cell lung (NSCL) cancer in mice by using an investigative drug called BEZ235 in combination with low-dose radiation.
Alternatively spliced tissue factor identified as promising new biomarker for aggressive cancers
A recently discovered form of the protein that triggers blood clotting may play a key role in the molecular mechanisms leading to the growth of certain metastatic cancers, according to new research reported by an international team of scientists.
Sensor biochips could aid in cancer diagnosis and treatment
It is very difficult to predict whether a cancer drug will help an individual patient: only around one third of drugs will work directly in a given patient.
Bioluminescence imaging used for eye cancer detection
At the moment, doctors rely on biopsy analysis to determine the progression of eye cancer. However, researchers now believe that a new technology, bioluminescence imaging (BLI), will allow doctors to detect tumors earlier and quickly choose a method of treatment that doesn't necessarily involve eye surgery.
Novel polymer delivers genetic medicine, allows tracking
Theresa M. Reineke, associate professor of chemistry in the College of Science, and colleagues in her lab at Virginia Tech and at the University of Cincinnati have developed a new molecule that can travel into cells, deliver genetic cargo, and packs a beacon so scientists can follow its movements in living systems.
NEDD9 Protein Supports Growth of Aggressive Breast Cancer
Researchers at Fox Chase Cancer Center have demonstrated that a protein called NEDD9 may be required for some of the most aggressive forms of breast cancer to grow. Their findings, based on the study of a mouse model of breast cancer, are presented in a recent issue of Cancer Research, available on-line now.
Experimental drug lets B cells live and lymphoma cells die
An investigative drug deprived non-Hodgkin lymphoma cells of their ability to survive too long and multiply too fast, according to an early study published recently in the journal Experimental Hematology.
Killing Cancer Like a Vampire Slayer
Like vampires, cancer tumors require an ample supply of blood to stay alive. Without fresh blood for sustenance, cancer cells shrivel up like raisins and die.
More Tumor Growth Current Events and Tumor Growth News Articles
|
Tumor Biology: Regulation of Cell Growth, Differentiation, and Genetics in Cancer (Nato a S I Series Series H, Cell Biology) by Differentiation, and Genetics in Cancer" (1995 : Porto Karras, Chalkidike, Greece) NATO Science Institute "Regulation of Cell Growth (Author), Asterios S. Tsiftsoglou (Editor), North Atlantic Treaty Organization. Scientific Affairs Division (Editor) This book provides both basic aspects and the latest findings in the molecular and cellular biology of malignant tumors. The focus is on the mechanisms by which normal and neoplastic cells proliferate, differentiate and undergo apoptosis. The differentiation of hemopoietic, epithelial and neuronal cells is treated with respect to growth factors, signal transduction, transcription factors, and genes regulating the cell cycle and the commitment to maturation. The role of oncogenes in neoplastic cell growth and cell death is also covered. The book deals with the regulation of globin gene expression by the LCR locus and the mechanisms of RNA stability for iron-binding and other proteins. The induction of differentiation of neoplastic cells as an alternative approach to cancer therapy is... | |
|
No. 571(Tumors, Growths) 1 oz by PROGRESSIVE LABS | |
 |
Charlie Rose with Anthony Robbins (July 19, 2000) Motivational speaker Anthony Robbins on his unusual career advising everyone from Andre Agassi and President Clinton to the IBM Corporation and the United States Army and the launch of his new website, www.dreamlife.com. This product is manufactured on demand using DVD-R recordable media. Amazon.com's standard return policy will apply. |
 |
Intracranial Tumor Canvas Print - Canvas Art by FineArtAmerica.com This is a beautiful stretched-canvas art print wrapped on 2.5" thick stretcher bars. The print is professionally printed, assembled, and shipped within 2 - 3 business days from our production facility in North Carolina and arrives ready-to-hang on your wall. FineArtAmerica.com is home to more than 20,000 artists from all over the world who entrust us to fulfill their print orders online. We offer a 30-day money-back guarantee on every print that we sell and look forward to helping you select your next piece. |
 |
Olympian Labs Ip-6, Inositol Hexaphosphate by Olympian Labs Inositol hexaphosphate is a sugar molecule attached to six phosphate molecules. It is found throughout nature, in wheat and rice bran, legumes such as soybeans and virtually every kind of mammalian cell. It plays an important role in regulating vital cellular functions including cell proliferation and differentiation. There has been research on human liver cancer cells that were treated with inositol hexaphosphate and transplanted into mice. They found that inositol hexaphosphate slowed or stopped the growth of liver cancer cells and shrank existing tumors three- to four-fold. Inositol hexaphosphate does not kill cancer cells - it tames them and makes them behave like normal cells. Inositol hexaphosphate decreases proliferation of cancer cells and causes them to differentiate,... |
|
Metastatic Tumor Growth (CNACER CAMPAIGN, 4) by E.GRUNDMANN (Editor) PROCEEDINGS OF THE11TH INTERNATIONAL SYMPOSIUM ON CANCER. DEALS WITH GROWTH OF TUMORS BY METASTIC SPREADING | |
|
Two drugs halted tumor growth in lung cancer.(Clinical Rounds): An article from: Family Practice News by Erik L. Goldman (Author) This digital document is an article from Family Practice News, published by International Medical News Group on September 1, 2004. The length of the article is 595 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Two drugs halted tumor growth in lung cancer.(Clinical Rounds) Author: Erik L. Goldman Publication: Family Practice News (Magazine/Journal) Date: September 1, 2004 Publisher: International Medical News Group Volume: 34 Issue: 17 Page: 60(1) Distributed by Thomson... | |
|
Peregrine's phospholipid-targeted antibodies fused wth cytokines reduce tumor growth.: An article from: BIOTECH Patent News by Gale Reference Team (Author) This digital document is an article from BIOTECH Patent News, published by Thomson Gale on September 1, 2006. The length of the article is 654 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Peregrine's phospholipid-targeted antibodies fused wth cytokines reduce tumor growth. Author: Gale Reference Team Publication: BIOTECH Patent News (Newsletter) Date: September 1, 2006 Publisher: Thomson Gale Volume: 20 Issue: 9 Distributed by Thomson... | |
|
Nonsteroidal anti-inflammatories may slow breast tumor growth. (Large, Case-Control Study).: An article from: Internal Medicine News by Michele G. Sullivan (Author) This digital document is an article from Internal Medicine News, published by International Medical News Group on January 15, 2003. The length of the article is 1357 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Nonsteroidal anti-inflammatories may slow breast tumor growth. (Large, Case-Control Study). Author: Michele G. Sullivan Publication: Internal Medicine News (Magazine/Journal) Date: January 15, 2003 Publisher: International Medical News Group Volume: 36 Issue: 2 Page: 24(1) Distributed by Thomson... | |
|
Mechanism of tumor growth in crowngall by Erwin F Smith (Author) |
| © 2009 BrightSurf.com |